The Food and Drug Administration today is alerting health care professionals and patients about early results of new studies for Paxil (paroxetine) suggesting that the drug increases the risk for birth defects, particularly heart defects, when women take it during the first three months of pregnancy. Paxil is approved for the treatment of depression and several other psychiatric disorders. FDA
boalica | Voted 
Paxil Birth Defects Class Action Lawsuit
Geschrieben von boalica 116 Tage vor (http://www.paxilbirthdefectclassaction.com)
« voriger1 nächster »